Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand CDFR0812 vs clomipramine vs sildenafil for premature ejaculation (Phase 3)
KCT0004362Phase 3Active, not recruiting
- Sponsor
- CTC Bio
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clomipramine + sildenafil in premature ejaculation (PE) (3 arms), sponsored by CTC Bio. Started Oct 2019; status: active, not recruiting.
02
Drugs
clomipramine + sildenafil
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on KCT0004362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004362.